The time and financial pressures drug development teams face is immense, and when factoring in failures and capital expenditures, the cost to develop a new drug increases fivefold
This page draws from regulatory sources, clinical-trial registries, peer-reviewed studies, PubMed-indexed literature, and scientific databases
Single peptide versus stack Individual BPC-157 or TB-500 use provides meaningful benefits for many applications
Dihexa or its analogs were administered 5 minutes after scopolamine, either intracerebroventricularly at doses of 0.1 or 1 nmol), intraperitoneally at doses of 0.05, 0.25, or 0.50 mg/kg, or orally at doses of 1.25 or 2.0 mg/kg
MECHANISM CATEGORIES SAFETY Side effects Generally well-tolerated in trials at the doses tested Injection-site reactions Known interactions Not characterized in Phase 3 Contraindications Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Not FDA-approved as a drug
Fountain of Youth IV Infusion - $300 A rejuvenating infusion targeting the whole body to detoxify, boost energy, reduce oxidative stress, and stimulate cellular repair